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The effect of heparin, administered prior to vessel dis- 
section and excision, on the luminal release of prostanoids 
from an excised vessel was assessed. Eight adult mongrel 
dogs underwent removal of the jugular vein and carotid 
artery on one side, followed by intravenous administra- 
tion of heparin sodium (150 IU/kg) and subsequent re- 
moval of these same vessels from the contralateral neck. 
The excised vessels were perfused in an ex viva system 
with Hanks’ balanced salt solution for five consecutive 
15-min periods. Prostacyclin release (measured as 6- 
keto-PGF& and thromboxane Az (measured as throm- 
boxane B,) release into the perfusate were quantitated 
by radloimmunoassay. Vessel segments were studied with 
and without first period thrombin stimulation (2 U/ml) 
and with arachidonic acid (4 wg/ml) stimulation during 
the last perfusion period. Vein segments following hep- 
arin administration exhibited greater prostacyclin pro- 
duction than veins not exposed to heparin. This effect did 
not occur in arteries. Heparin did not influence throm- 
boxane Ax release. Luminal endothelial cell coverage was 
not affected by the presence or absence of heparin. Thus 
heparin anticoagulation prior to dissection and excision 
of a vein, may enhance early preservation of its endo- 
thelial cell function as evident by increased luminal re- 
lease of prostacyclin. 0 1989 Academic PEWS, me. 
INTRODUCTION 
Autogenous blood vessels are preferred conduits for 
most small vessel reconstructions. The higher patency of 
such grafts compared to prosthetic grafts, especially in 
low-flow situations, has been attributed in part to the 
antithrombotic properties of endothelium. Endothelial 
cells are the major source of prostacyclin (PG12), a pow- 
erful vasodilator and antagonist of platelet aggregation. 
The prostaglandin thromboxane AZ (TxA,), a vasocon- 
strictor and a stimulus for platelet aggregation, has as its 
primary source platelets, although some TxA2 is produced 
by components of the vessel wall including endothelium 
[ 1, 21. A favorable balance between PGIz and TxAz may 
be important in maintaining vessel patency. 
Certain failures of autogenous artery and vein grafts 
have been attributed to endothelial damage occurring 
during procurement and preparation procedures. Exces- 
sive dissection, overzealous distension of the vessel, pro- 
longed exposure to crystalloid solutions, and vasospasm 
have been implicated as causes of endothelial cell injury 
[3]. Thrombin or fibrin produced as a result of thrombin 
generation may also be harmful to endothelium [4, 51. 
Heparin, by facilitating the action of endogenous anti- 
thrombins, may inhibit generation of thrombin and 
thrombin-catalyzed conversion of fibrinogen to fibrin and 
thus protect the integrity of endothelial cells [6, 71. The 
purpose of this experiment was to document the effect of 
heparin administration prior to vessel harvest on endo- 
thelial cell function as manifest by prostanoid production. 
MATERIALS AND METHODS 
Vessel harvest. Eight adult mongrel dogs were anes- 
thetized with pentobarbital and mechanically ventilated. 
Through a midline neck incision a carotid artery and ip- 
silateral external jugular vein were dissected. These ves- 
sels were excised independently and prepared for er viva 
perfusion. Heparin sulfate (150 units/kg) was then ad- 
ministered intravenously, and the contralateral carotid 
artery and jugular vein were harvested in a manner similar 
to that of the opposite side. These vessels were also per- 
fused independently. Animal care was carried out in ac- 
cordance with Principles of Laboratory Animal Care and 
Guide for The Care of and Use of Laboratory Animals (NIH 
publication No. 80-23, Revised, 1976). 
Vessel perfusion. Each excised vein and artery was 
gently flushed immediately following excision with room- 
temperature calcium- and magnesium-free Hanks’ bal- 
anced salt solution (CMF-HBSS) (GIBCO, Grand Island, 
NY) which had been adjusted to pH 7.4. Vessels were 
then divided into two equal segments, 30-40 mm in length, 
and mounted in the perfusion system. Prior to the first 
perfusion the vessel segments were flushed with 25 ml of 
CMF-HBSS to remove any prostaglandins released during 
the mounting process. The vessel segments were perfused 
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with 25 ml of HBSS (GIBCO, Grand Island, NY) adjusted 
to a pH of 7.4 at 37°C in a recirculating loop for five 
separate 15-min periods [8]. At the conclusion of each 
15-min perfusion, the perfusate was collected and replaced 
with new HBSS. Perfusate samples were stored at -20°C 
until subsequent prostanoid assays were performed. 
Veins were perfused with nonpulsatile flow, created by 
placing a Windkessel device in the circuit, at a rate of 90 
ml/min and a pressure of 7 mm Hg. Arteries were perfused 
with pulsatile flow of 90 ml/min and a mean pressure of 
100 mm Hg. Fifty units of human thrombin (T-7009, 
Sigma, St. Louis, MO) was added to the first perfusate in 
one segment from each vessel. Arachadonic acid 100 pg 
(A-6382, Sigma, St. Louis, MO) was added to the last 
perfusate of all vessel segments tested. 
Scanning electron microscopy. Vessel segments were 
perfusion-fixed after the prostanoid release studies in 
2.5% glutaraldehyde with 0.1 M cacodylate. The vessels 
were dehydrated in ethanol, air-dried after saturation with 
hexamethyldisilazane, and sputter-coated with gold-pal- 
ladium. The percentage of luminal endothelial cell cov- 
erage was estimated by scanning electron microscopy. Five 
separate areas were examined on each vessel segment, 
being scored 0, 1, or 2. A score of 0 corresponded to absence 
of endothelium and 2 represented an intact layer of en- 
dothelium. The sum of the scores of the five areas defined 
the surface coverage (sum X 10 = percentage coverage). 
Prostanoid analysis. Prostacyclin and thromboxane 
AZ production were determined by measuring their stable 
breakdown products 6-keto-PGFicu and thromboxane Bz 
(TxB,). These prostaglandins were extracted from the 
perfusate samples using a modification of the method de- 
scribed by Simmons and colleagues in which proteins were 
precipitated with acetonitrile and discarded, with the su- 
pernatant being acidified with formic acid prior to ethyl 
acetate extraction [9]. These samples were air-dried and 
redissolved in 0.1% gel phosphate-buffered saline. 6-keto- 
PGFi(w and TxBs were measured with commercial RIA 
kits using a 3H tracer (New England Nuclear, Boston, 
MA). The sample values were determined from a standard 
curve calculated for each run. 
Data are expressed as means f 1 SEM. Statistical sig- 
nificance was determined with a paired t test comparing 
the pre- and postheparin segments in the same animal. 
RESULTS 
Prostacyclin release from arteries was generally 5 to 10 
times greater than from veins (Table 1, Figs. 1 and 2). 
Both arteries and veins exhibited a similar pattern of de- 
creasing prostacyclin production during the 75-min per- 
fusion. Arachidonic acid addition to the last 15-min per- 
fusate caused prostacyclin production to reach or exceed 
that released during the first perfusion period. Thrombin 
added to the first 15-min perfusate caused both arteries 
and veins to release greater amounts of prostacyclin dur- 
ing that period. 
Prostacyclin release from veins harvested after heparin 
administration was 50 to 100% higher than release from 
veins harvested prior to heparin anticoagulation. The 
higher release under these circumstances was statistically 
significant for both the thrombin-stimulated and the non- 
thrombin-stimulated veins (P = 0.001 and 0.05, respec- 
tively). Greater prostacyclin production following heparin 
administration did not occur with arteries. 
Thromboxane release was minimal in both arteries and 
veins (Table 2, Figs. 3 and 4). A two- to fourfold increase 
in measured TxBz occurred with arachidonic acid sup- 
TABLE 1 
Vessel Segment 6-keto-PGF,cr Release with and without Heparin Anticoagulation Prior to Excision 
O-15 min 15-30 min 30-45 min 45-60 min 60-75 min* P value’ 
Vein 
No heparin 8f 1 4fl 5+1 
Heparin 13+ 4 11 f 3 12 + 3 
Vein (thromhin)” 
No heparin 152 3 6+1 5+1 
Heparin 18f 4 11 f 2 8+1 
Artery 
No heparin 81 f 13 27 iz 4 16 + 3 
Heparin 77* 7 31 * 5 27 + 7 
Artery (thrombin)” 
No heparin 117 + 18 33 + 5 20 rt 6 
Heparin 127 f 24 41 * 9 23 k 4 
Note. Data are expressed as means -C SEM. 
’ Thrombin (final concentration 2 units/ml) added during first perfusion period only. 
b Arachadonic acid (final concentration 4 pg/ml) added during this period. 
’ Heparin vs no heparin groups (paired t test). 
4fl 39+ 6 0.05 
10 f 3 29+ 6 
451 29f 5 0.001 
7fl 36f 7 
15 iz 3 118+ 8 0.7 
17 + 2 114 f 13 
14 + 3 108f 9 0.1 
15 f 2 141 f 18 
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FIG. 1. Vein segment 6-keto-PGFicY release with and without first period thrombin stimulation. Error bars represent 1 SEM. Preheparin vs 
postheparin; P = 0.05 (no thrombin), P = 0.001 (thrombin). ARA, arachidonic acid. 
plementation, but TxBz levels never exceeded 10% of the 
measured 6-keto-PGFia in either arteries or veins during 
similar time periods. No differences existed in thrombox- 
ane release from vessels harvested before or after heparin 
anticoagulation. 
Luminal endothelial cell coverage averaged 50 to 80% 
following perfusion, with the percentage coverage being 
similar regardless of whether vessels were harvested before 
or after heparin administration (Fig. 5). 
DISCUSSION 
In this study, heparin administered prior to vein re- 
moval resulted in higher production of prostacyclin as 
measured in an ex viva perfusion system. Similar increases 
in prostacyclin production from arteries were not observed 
in the heparin group. There was no significant difference 
NO THROMBIN 
PRE HEPARIN ARA 
in endothelial cell coverage of vessels harvested without 
heparin exposure compared to those harvested after hep- 
arin administration. Since the major source of prostacy- 
clin synthesis is endothelium, this suggests that the ob- 
served differences were actually due to higher prostacyclin 
production, not greater endothelial retention. However 
since endothelial cell coverage was determined after ex 
viuo perfusion, it is possible that better endothelial re- 
tention did occur in the heparin group, but that the dif- 
ference between groups was masked by the effects of per- 
fusion. It is also possible that prostacyclin production is 
a more sensitive quantitative indicator of endothelial 
coverage than the relatively crude method of estimating 
surface coverage by scanning electron microscopic ex- 
amination of random areas. 
Heparin does not have a direct effect on endothelial 
cell prostacyclin production [ 10, 111. However, it is likely 
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FIG. 2. Artery segment 6-k&o-PGFior release with and without first period thrombin stimulation. Preheparin vs postheparin: P = 0.7 (no 
thrombin), P = 0.1 (thrombin). 
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TABLE 2 
Vessel Segment TxBz Release with and without Heparin Anticoagulation Prior to Excision 
o-15 15-30 30-45 
min min min 
Vein 
No heparin 0.7 k 0.2 0.3 t 0.1 0.3 * 0.1 
Heparin 0.7 * 0.1 0.3 2 0.1 0.3 f 0.1 
Vein (thrombin) 
No heparin 0.5 f 0.1 0.3 + 0.1 0.3 f 0.1 
Heparin 0.7 + 0.2 0.3 + 0.1 0.2 f 0.1 
Artery 
No heparin 1.0 + 0.1 0.8 + 0.1 0.6 + 0.1 
Heparin 1.7 + 0.5 0.8 f 0.2 0.4 f 0.1 
Artery (thrombin)” 
No heparin 1.6 + 0.2 0.9 f 0.2 0.7 + 0.1 
Heparin 1.8 f 0.3 0.8 + 0.2 0.5 + 0.1 
Note. Data are expressed as means k SEM. 
’ Thrombin (final concentration 2 units/ml) added during first perfusion period only. 
b Arachadonic acid (final concentration 4 pg/ml) added during this period. 
45-60 60-75 
min min* 
0.2 + 0.1 1.9 f 0.2 
0.3 f 0.1 2.2 f 0.3 
0.2 + 0.1 1.9 f 0.3 
0.2 2 0.1 1.9 + 0.1 
0.6 f 0.1 4.0 f 0.5 
0.6 + 0.1 3.9 F 0.4 
0.6 f 0.1 3.9 + 0.4 






’ Heparin vs no heparin groups (paired t test). 
that the effect of thrombin generated due to the mechan- 
ical trauma of harvesting blood vessels is lessened by hep- 
arin administration, and this antithrombin activity ac- 
counts for increased prostacyclin production. 
Lower and less variable prostacyclin production from 
rabbit aorta and vena cava segments in animals heparin- 
ized prior to vessel harvest has been reported by others 
[lo]. The results of this latter study may appear to be the 
opposite of the current investigation, yet in fact these 
findings may be consistent with our observations, in that 
the former studies involved assessment of prostacyclin 
production immediately after vessel harvest and without 
a perfusion stimulus. In the current study, the 20- to 40- 
min lag between vessel procurement and onset of perfu- 
NO THROMBIN 
m PRE HEPARIN AM 
= POST HEPARIN 
.L 
sion, along with the flushing of vessels to eliminate pros- 
tacyclin produced in vivo and during the mounting, should 
have minimized the residual effects of in viuo stimuli. En- 
dothelial cells exposed to thrombin are known to become 
refractory to further thrombin-stimulated release of 
prostacyclin [12, 131. Prostacyclin production by vein 
segments not exposed to heparin may reflect a refractory 
state induced by thrombin stimulation during the harvest 
process. Prior heparin exposure may protect the vessel 
from the effects of thrombin. 
The increase in prostacyclin production with arachi- 
donic acid supplementation is consistent with other stud- 
ies that demonstrated a response to arachidonic acid after 




FIG. 3. Vein segment TxBr release with and without first period thrombin stimulation. Preheparin vs postheparin: P = 0.5 (no thrombin), 
P = 0.5 (thrombin). 
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FIG. 4. Artery segment TxBz release with and without first period thrombin stimulation. Preheparin vs postheparin: P = 0.9 (no thrombin), 
P = 0.5 (thrombin). 
It has been suggested that the stimulatory effect of 
thrombin on prostacyclin production is mediated through 
increasing release of endogenous arachidonic acid from 
membrane phospholipids and that the refractoriness to 
further thrombin stimulation is due to a block at this 
level [ 141. If the lower prostacyclin production in the no- 
heparin group is due to a block at the level of endogenous 
arachidonate release, this block would be bypassed by ex- 
ogenous arachidonic acid administration. 
The apparent lack of a protective effect of heparin on 
arterial prostacyclin production may be due to differences 
in arterial and venous endothelium. Arterial prostacyclin 
production is known to be greater than venous production, 
given the same endothelial cell surface area [X5,16]. Oth- 
ers have shown canine artery and vein to differ in endo- 
thelial cell response to thrombin, with thrombin causing 
endothelial-dependent arterial relaxation, but endothelial- 
dependent venous contraction [ 171. Differences have also 
been noted in the endothelial cell prostacyclin release fol- 
lowing thrombin exposure, depending on the source of 
endothelium [ 18,191. In this regard, thrombin generation 
during vessel harvest may have less of aneffect on arterial 
than venous endothelium. 
The clinical implications of this study are undefined. 
It is likely that the advantages of vein grafts over pros- 
thetic grafts in lower extremity reconstructions is due at 
least in part to the thromboresistant nature of endothe- 
lium, of which prostacyclin production is an important 
component. Better functional preservation of the endo- 
thelial cell capacity for prostacyclin production may re- 
duce early platelet deposition after placement of vein 
grafts in the arterial circulation. In this regard, admin- 
istration of heparin prior to beginning dissection of a vein 
intended for use as an arterial substitute may reduce cer- 
tain potentially harmful effects of thrombin generated 
during the dissection process. 
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FIG. 5. Luminal surface area coverage by endothelium after perfusion as determined by scanning electron microscopy. 
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